Review



well plates  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    OriGene well plates
    Well Plates, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/CD18+(ITGB2)+(NM_001127491)+Human+Recombinant+Protein/pm29125705-211-2-14
    Average 90 stars, based on 2 article reviews
    well plates - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Mycobacterium tuberculosis Mce3C promotes mycobacteria entry into macrophages through activation of β2 integrin-mediated signalling pathway.
    Article Snippet: .. In brief, 96-well plates were coated with 250 ng of human β2 integrin (TP326157, ORIGENE), followed by overnight incubation at 4 °C. ..

    Recombinant:

    Article Title: Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-κB Signaling.
    Article Snippet: The membrane-permeable ITGA1-tail peptide (α1-TAT) and scrambled peptide (ScrTAT) were from Lifetein. .. Recombinant fulllength human ITGAL-ITGB2 was from Origene. .. Recombinant GST-RNF31 and GST-SHARPIN (WT, fragments and point mutants) were produced in the E. coli strain Rosetta BL21DE3 and purified according to manufacturer’s instructions (BD Biosciences).



    Similar Products

    94
    Miltenyi Biotec cd18
    Antibodies panel for MICS
    Cd18, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/CD18+Antibody%2C+anti-mouse%2C+REAfinity/pmc13573706-4-0-10
    Average 94 stars, based on 1 article reviews
    cd18 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Hycult Biotech anti cd18 antibodies
    Antibodies panel for MICS
    Anti Cd18 Antibodies, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/CD11%2FCD18+(LFA-1)%2C+Human%2C+mAb+24/bio_rxiv__64898__2026__03__20__713251-241-25-40
    Average 90 stars, based on 1 article reviews
    anti cd18 antibodies - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    95
    Proteintech itgb2 cd18
    Antibodies panel for MICS
    Itgb2 Cd18, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/CD18+Polyclonal+antibody/pm42827616-55-25-26
    Average 95 stars, based on 1 article reviews
    itgb2 cd18 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Proteintech anti itgb2 cd18
    Antibodies panel for MICS
    Anti Itgb2 Cd18, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/CD18+Polyclonal+antibody/10__1038_slash_s41698___026___01703___8-343-27-29
    Average 95 stars, based on 1 article reviews
    anti itgb2 cd18 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    92
    ABclonal Biotechnology cd18
    Antibodies panel for MICS
    Cd18, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/CD18+Rabbit+pAb/pm42625356-108-46-48
    Average 92 stars, based on 1 article reviews
    cd18 - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    97
    ATCC cell lines hpne dr michel ouellette n a suit 2 dr michel ouellette n a cd18 hpaf ii atcc cat
    Antibodies panel for MICS
    Cell Lines Hpne Dr Michel Ouellette N A Suit 2 Dr Michel Ouellette N A Cd18 Hpaf Ii Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/HPAF-II/pm42250222-335-106-119
    Average 97 stars, based on 1 article reviews
    cell lines hpne dr michel ouellette n a suit 2 dr michel ouellette n a cd18 hpaf ii atcc cat - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    93
    Bio-Rad ○ cd18 mouse anti dog
    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for <t>CD18,</t> CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.
    ○ Cd18 Mouse Anti Dog, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/Mouse+anti+Dog+CD18/pmc13049955-44-72-79
    Average 93 stars, based on 1 article reviews
    ○ cd18 mouse anti dog - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank cd18
    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and <t>CD11a/CD18</t> LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).
    Cd18, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/anti-CD18/pmc13177288-47-12-18
    Average 94 stars, based on 1 article reviews
    cd18 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems cd18 ß2 integrin r d systems fab1730r 100ug
    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and <t>CD11a/CD18</t> LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).
    Cd18 ß2 Integrin R D Systems Fab1730r 100ug, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/Human+Integrin+beta+2%2FCD18+Alexa+Fluor%C2%AE+647-conjugated+Antibody/pm41863801-143-220-222
    Average 94 stars, based on 1 article reviews
    cd18 ß2 integrin r d systems fab1730r 100ug - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Proteintech cd18
    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and <t>CD11a/CD18</t> LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).
    Cd18, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd18/CD18+Fusion+Protein/pm41831321-247-67-68
    Average 94 stars, based on 1 article reviews
    cd18 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Antibodies panel for MICS

    Journal: iScience

    Article Title: Integrated 3D light sheet and 2D multiplex imaging for deep histological characterization of somatic mouse glioblastoma

    doi: 10.1016/j.isci.2026.117476

    Figure Lengend Snippet: Antibodies panel for MICS

    Article Snippet: CD18 , REA1226 , 50 , 130-124-120 , APC , Miltenyi Biotec.

    Techniques:

    Antibodies panel for MICS on 2D3D

    Journal: iScience

    Article Title: Integrated 3D light sheet and 2D multiplex imaging for deep histological characterization of somatic mouse glioblastoma

    doi: 10.1016/j.isci.2026.117476

    Figure Lengend Snippet: Antibodies panel for MICS on 2D3D

    Article Snippet: CD18 , REA1226 , 50 , 130-124-120 , APC , Miltenyi Biotec.

    Techniques:

    Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for CD18, CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.

    Journal: MethodsX

    Article Title: Feline leukocyte immunophenotyping: an optimised whole-blood flow cytometry protocol

    doi: 10.1016/j.mex.2026.103869

    Figure Lengend Snippet: Representative leukocyte-gated histograms illustrating antibody titration for feline leukocyte immunophenotyping. All histograms display singlet leukocytes, defined by FSC-A versus SSC-A morphological gating, followed by FSC—H versus FSC-A singlet discrimination. Titration was performed for CD18, CD21, CD45R, CD4, CD5 and CD8 monoclonal antibodies using three antibody volumes: 10 µL (1:10 dilution), 5.0 µL (1:20 dilution), 3.0 µL (1:33 dilution) and 1.5 µL (1:66 dilution). Minimal working volumes were selected based on optimal signal-to-noise ratios.

    Article Snippet: Step 2 – Leukocytes extracellular staining Materials • EDTA Whole blood sample ± Transfix® • 200 μl pipettes • 100 μl pipettes • 10 μl pipettes • Flow cytometry tubes • Permanent marker • Cytometer tube rack Reagents • Monoclonal antibodies: ○ CD5 Anti-cat – clone FE1.1B11 (BIO-RAD®) ○ CD4 Anti-cat – clone vpg34 (BIO-RAD®) ○ CD8 Anti-cat alpha/beta purified – clone vpg9 (BIO-RAD®) ○ Rat Anti-Mouse IgG1 – clone X56 (BIO-RAD®) ○ CD18 Mouse Anti-Dog – clone CA1.4E9 (BIO-RAD®) ○ CD21 Mouse Anti-Dog – clone CA2.1D6 (BIO-RAD®) ○ CD45R Rat Anti-Mouse – clone RA3–6B2 (BIO-RAD®) • 10x Red blood cells (RBC) lysis buffer solution (BD FACSTM lysing solution) • PBS 1% solution Equipment • Countess TM 3 (Thermo Fisher Scientific, USA) • Freezer • Dark incubation chamber • Timer • Vortex (MX-S®, China) • Centrifuge (model 5810R, Eppendorf®, Germany) • Flow cytometry analyser BD FACSCanto II (Becton Dickinson (BD), San Jose, USA) Methods 1.

    Techniques: Titration, Bioprocessing

    Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and CD11a/CD18 LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).

    Journal: Analytical Chemistry

    Article Title: Immunomagnetic Sample Preparation Targeting Host- and Viral-Derived Antigens for HIV‑1 Isolation from Limited Plasma Volumes

    doi: 10.1021/acs.analchem.5c06176

    Figure Lengend Snippet: Immunoconjugate-mediated capture of HIV-1 from clinical specimens. Five specimens with viral loads ranging from 107,024 to 1,393,440 copies/mL were used. n = 2–3 technical replicates/specimen and n = 3–5 clinical specimens/conjugate, except gp120, gp41, CD45, CD86, ICAM-1, and CD11a/CD18 LFA-1 ( n = 1 specimen) were used. A. % Captured HIV-1 by immunoconjugates incubated with HIV-positive plasma. Healthy human plasma acted as a negative control. Beads or isotype controls show nonspecific capture of HIV-1. B. Captured HIV-1 RNA copies by immunoconjugates incubated with 25 μL patient specimens. C. Captured HIV-1 RNA copies by CD46 immunoconjugate incubated with increasing volumes of HIV-positive plasma (ID #1654, VL: 384,000 copies/mL), ranging from 2 to 50 μL ( n = 2–3 technical replicates). D. % Captured HIV-1 by the combination of CD46 and CD44 immunoconjugate incubated with patient plasma (ID #1654, VL: 384,000 copies/mL). CD44 (1.6 mg) and CD46 (1.6 mg) were used alone or in combination (0.8 mg each, total 1.6 mg). The no capture control shows the input copies present in 25 μL of HIV-positive human plasma, measured by RT-qPCR. The isotype control shows nonspecific capture by IgG isotype armed microbeads. No-capture control served as the baseline HIV RNA copies in the different plasma volumes ( n = 1–3 replicates).

    Article Snippet: Mouse IgG antibodies: CD8 (UCH-T4), Cat # sc-1181, Santa Cruz Biotechnology, Inc.; CD18 (Integrin beta-2), Clone ID H52-s, DSHB (Developmental Studies Hybridoma Bank); HIV1gp120, Cat # sc-57810, Santa Cruz Biotechnology, Inc.; CD26, Cat # 555435, BD Pharmingen; integrin alpha-4, Clone ID P4G9, DSHB; CD43 (DF-T1), Cat # sc-6256, Santa Cruz Biotechnology, Inc.; CD46 (1E3D1), Cat # MA5-29113, Invitrogen; β 2 -microglobulin (B2M-01), Cat # MA1–19141, Invitrogen; integrin alpha-L (CD11a), Clone ID MHM.24, DSHB; CD86 (B7-2), Clone ID IT2.2, Invitrogen; CD44, Clone ID H4C4, DSHB; ICAM1, Clone ID P2A4, DSHB; CD45, Clone ID H5A5, DSHB; HLA-DR, Clone ID LN3, Cat # 14-9956-82, Thermo Fisher Scientific; Tim-4 (human):Fc (mouse) (rec.), Cat # CHI-HF-211T4-C100, AdipoGen Life Sciences.

    Techniques: Incubation, Clinical Proteomics, Negative Control, Control, Quantitative RT-PCR